San Pedro, CA. The Worthington & Caron Law Firm is pleased to report that on August 30, 2023, a Cook County, Illinois jury returned a $40.75 million verdict in favor of our clients, the family of Bruce Torgerson, deceased, against John Crane, ...

Juliet Gray is just one of the nearly 40,000 talc plaintiffs waiting for their day in court against pharmaceutical giant, Johnson & Johnson (J&J). J&J has been in the midst of contesting recent rejections of their controversial bankruptcy ...

In the ongoing legal battle involving Johnson & Johnson’s use of the much-criticized Texas Two-Step, J&J now plans to appeal to the U.S. Supreme Court. We previously reported J&J’s loss in the 3 rd Circuit Court of Appeals ...

In 2017 industrial giant Georgia Pacific was the first company to create a subsidiary unit to offload its asbestos litigation liability which then declared bankruptcy. The tactic is now referred to as the Texas Two-Step and is being used by more and ...

A Phase 1 safety study of single-agent immunotherapy drug, Avelumab, combined with stereotactic body radiation therapy (SBRT) was well-tolerated by mesothelioma patients with no severe side effects. The study was led by researchers from Memorial ...

ProPublica has released a must-read investigative report on the remaining hold-out in the total ban of asbestos in America, the chlor-alkali industry. Specifically, two chemical companies, OxyChem and Olin Corp., whose insistence upon using ...

Hikers gathered on a beautiful, clear Sunday last month to commemorate the Pacific Mesothelioma Center’s 11th Annual Walk/Hike for Mesothelioma. In-person participants were greeted by ample sunshine and expansive city and mountain views atop ...

Researchers from Rice University and Baylor College of Medicine have managed to eradicate advanced-stage mesothelioma tumors within days on rodent subjects, laying the groundwork for future human trials. By combining cytokine “drug ...

U.S. Representative Elaine Luria of Virginia has introduced legislation to prohibit state courts from removing cases to the federal court system. Throughout the United States, when asbestos victims seek restitution from the companies that knowingly ...

The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...

This past April, the Environmental Protection Agency proposed banning the use, manufacture and import of the most pervasive type of asbestos, chrysotile. Although advocates continued to demand a complete ban of all forms of asbestos, the EPA’s ...

As Europe aims to reach climate neutrality by 2050, it is grappling with the risk of exposing construction workers to asbestos. Although admirable, Europe’s goal to renovate 220 million buildings in order to “slash energy emissions, ...

SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...